Block Listing Application

RNS Number : 9030F

GSK PLC

10 November 2022

GSK plc

Block listing Application

Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 1,400,000 Ordinary Shares of 31¼p each ('Shares') to be admitted to the Official List.

The Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2022 and GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan.

When issued, the Shares will rank pari passu with the existing Ordinary Shares of 31¼p each.

Admission is expected to be effective on 11 November 2022.

V A Whyte

Company Secretary

10 November 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSBKCBKCBDDNDK

TIDM	GSK
Share Price	1,845.50p-0.40%
Market Cap	£79.66bn

Date	10 Nov 2022
Time	09:00:01
Category	Capital structure
ID	9030F

TIDM	GSK
Share Price	1,845.50p-0.40%
Market Cap	£79.66bn

Date	10 Nov 2022
Time	09:00:01
Category	Capital structure
ID	9030F

t

Company Information

RNS Metadata

Company Information

RNS Metadata

Block Listing Application